# Clinical and Translational Science Award

> **NIH NIH UL1** · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · 2020 · $2,218,427

## Abstract

PROJECT SUMMARY
 Increasingly, the effective translation of groundbreaking biomedical discoveries and successful adoption of
evidence-based therapies and interventions aimed to improve population health and reduce health disparities
requires the coordinated efforts of multi-disciplinary and multi-sectoral partnerships with diverse expertise,
interests, and skills. The New York University (NYU)-Health and Hospitals Corporation (HHC) Clinical and
Translational Science Institute (CTSI) represents an innovative public-private research partnership designed to
foster clinical and translational research and transform the delivery of care in clinical and community practice.
With this application, we have assembled a partnership of institutions with unique and complementary
strengths: a private research university with a history of public service and substantial biomedical, behavioral,
and population health expertise (NYU), the largest municipal healthcare system in the United States (HHC), a
state psychiatric institute (Nathan Kline Institute), and various community organizations that represent the rich
diversity of populations in NYC. As the centralized hub, our CTSI catalyzes research and facilitates access to
essential core services, resources, and expertise necessary to engage in the full spectrum of clinical and
translational research across our partner institutions. Moreover, the CTSI serves as a nexus for collaboration
between investigators at our partner institutions and the nationwide network of CTSA hubs. We will build on
our success in markedly expanding clinical and translational research at our hub and an established history of
research collaboration between NYU and HHC to further accelerate the pace and impact of discovery,
development, validation, and implementation across the full spectrum of translational research. To accomplish
this goal, we propose an array of innovative and evidence-based strategies delineated in our application, all
within the framework of six overarching Specific Aims. 1) Catalyze and support innovative, collaborative
translational research that improves health across the lifespan in our diverse communities. 2) Ensure the
quality, safety, and efficiency of local clinical and translational research and to disseminate successful
approaches. 3) Stimulate, support, and disseminate innovative methods in the clinical and translational
sciences. 4) Foster community-engaged collaborative and team-based science among our diverse community
of investigators and stakeholders, rich array of partner institutions, and the national CTSA network. 5) Educate,
train, and cultivate the next generation of the translational research workforce. 6) Integrate our clinical,
education, and research missions and operations to foster a learning healthcare system.

## Key facts

- **NIH application ID:** 10174469
- **Project number:** 3UL1TR001445-05S1
- **Recipient organization:** NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- **Principal Investigator:** BRUCE Neil CRONSTEIN
- **Activity code:** UL1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $2,218,427
- **Award type:** 3
- **Project period:** 2015-08-18 → 2021-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10174469

## Citation

> US National Institutes of Health, RePORTER application 10174469, Clinical and Translational Science Award (3UL1TR001445-05S1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10174469. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*